Resultados da pesquisa - Khattak, Adnan

Etiology of white pupillary reflex in pediatric age group Por Israr, Muhammad, Zahir, Khalil Khan, Khattak, Adnan, Khattak, Irfan Ullah, Gul, Nazli

Obter o texto integral Obter o texto integral Obter o texto integral

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma Por Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic

Obter o texto integral Obter o texto integral Obter o texto integral

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort Por Tan, Benjamin, Khattak, Adnan, Felip, Enriqueta, Kelly, Karen, Rich, Patricia, Wang, Ding, Helwig, Christoph, Dussault, Isabelle, Ojalvo, Laureen S., Isambert, Nicolas

Obter o texto integral Obter o texto integral Obter o texto integral

Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study Por Lee, Dae Ho, Tsao, Ming-Sound, Kambartel, Karl-Otto, Isobe, Hiroshi, Huang, Ming-Shyan, Barrios, Carlos H., Khattak, Adnan, de Marinis, Filippo, Kothari, Smita, Arunachalam, Ashwini, Cao, Xiting, Burke, Thomas, Valladares, Amparo, de Castro, Javier

Obter o texto integral Obter o texto integral Obter o texto integral

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study Por Jazieh, Abdul Rahman, Akbulut, Hakan, Curigliano, Giuseppe, Rogado, Alvaro, Alsharm, Abdullah Ali, Razis, Evangelia D., Mula-Hussain, Layth, Errihani, Hassan, Khattak, Adnan, De Guzman, Roselle B., Mathias, Clarissa, Alkaiyat, Mohammad Omar Farouq, Jradi, Hoda, Rolfo, Christian

Obter o texto integral Obter o texto integral Obter o texto integral

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary An... Por Eggermont, Alexander M. M., Kicinski, Michal, Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander, Robert, Caroline, Suciu, Stefan

Obter o texto integral Obter o texto integral Obter o texto integral

Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis Por Bhave, Prachi, Pallan, Lalit, Long, Georgina V., Menzies, Alexander M., Atkinson, Victoria, Cohen, Justine V., Sullivan, Ryan J., Chiarion-Sileni, Vanna, Nyakas, Marta, Kahler, Katharina, Hauschild, Axel, Plummer, Ruth, Trojaniello, Claudia, Ascierto, Paolo A., Zimmer, Lisa, Schadendorf, Dirk, Allayous, Clara, Lebbe, Celeste, Maurichi, Andrea, Santinami, Mario, Roy, Severine, Robert, Caroline, Lesimple, Thierry, Patel, Sapna, Versluis, Judith M., Blank, Christian U., Khattak, Adnan, Van der Westhuizen, Andre, Carlino, Matteo S., Shackleton, Mark, Haydon, Andrew

Obter o texto integral Obter o texto integral Obter o texto integral

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial Por Eggermont, Alexander M. M., Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria G., Dalle, Stéphane, Haydon, Andrew M., Meshcheryakov, Andrey, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., van Akkooi, Alexander C. J., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline

Obter o texto integral Obter o texto integral Obter o texto integral

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma Por Bhave, Prachi, Ahmed, Tasnia, Lo, Serigne N, Shoushtari, Alexander, Zaremba, Anne, Versluis, Judith M, Mangana, Joanna, Weichenthal, Michael, Si, Lu, Lesimple, Thierry, Robert, Caroline, Trojanello, Claudia, Wicky, Alexandre, Heywood, Richard, Tran, Lena, Batty, Kathleen, Dimitriou, Florentia, Stansfeld, Anna, Allayous, Clara, Schwarze, Julia K, Mooradian, Meghan J, Klein, Oliver, Mehmi, Inderjit, Roberts-Thomson, Rachel, Maurichi, Andrea, Yeoh, Hui-Ling, Khattak, Adnan, Zimmer, Lisa, Blank, Christian U, Ramelyte, Egle, Kähler, Katharina C, Roy, Severine, Ascierto, Paolo A, Michielin, Olivier, Lorigan, Paul C, Johnson, Douglas B, Plummer, Ruth, Lebbe, Celeste, Neyns, Bart, Sullivan, Ryan, Hamid, Omid, Santinami, Mario, McArthur, Grant A, Haydon, Andrew M, Long, Georgina V, Menzies, Alexander M, Carlino, Matteo S

Obter o texto integral Obter o texto integral Obter o texto integral